PEAK6 Investments’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$4.74M Buy
19,400
+15,300
+373% +$3.42M 0.01% 963
2024
Q2
$785K Sell
4,100
-40,600
-91% -$8.24M ﹤0.01% 1988
2024
Q1
$8.85M Buy
44,700
+11,000
+33% +$2.02M 0.02% 571
2023
Q4
$5.8M Sell
33,700
-67,200
-67% -$10.3M 0.02% 742
2023
Q3
$14.9M Buy
100,900
+100,500
+25,125% +$18.2M 0.07% 251
2023
Q2
$87.4K Buy
+400
New +$89.2K ﹤0.01% 3282
2023
Q1
Sell
-11,200
Closed -$2.33M 4860
2022
Q4
$2.33M Buy
11,200
+9,100
+433% +$2M 0.01% 1223
2022
Q3
$458K Buy
2,100
+800
+62% +$182K ﹤0.01% 2955
2022
Q2
$276K Sell
1,300
-3,400
-72% -$724K ﹤0.01% 4457
2022
Q1
$1.14M Buy
4,700
+4,200
+840% +$1.02M ﹤0.01% 2378
2021
Q4
$130K Buy
+500
New +$130K ﹤0.01% 4235
2021
Q1
Sell
-14,500
Closed -$3.08M 5442
2020
Q4
$3.08M Sell
14,500
-12,100
-45% -$2.41M 0.01% 1481
2020
Q3
$4.56M Buy
26,600
+19,300
+264% +$3.56M 0.01% 1016
2020
Q2
$1.4M Sell
7,300
-37,100
-84% -$6.07M ﹤0.01% 1797
2020
Q1
$6.54M Buy
+44,400
New +$7.07M 0.04% 432
2019
Q2
Sell
-23,500
Closed -$2.44M 4202
2019
Q1
$2.44M Sell
23,500
-1,000
-4% -$103K 0.01% 1165
2018
Q4
$2.79M Buy
24,500
+8,700
+55% +$932K 0.02% 998
2018
Q3
$1.82M Buy
+15,800
New +$1.73M 0.01% 1500

Other funds holding RMD

PEAK6 Investments's RMD Position: Q3 2024 in Review

PEAK6 Investments increased its ResMed (RMD) stake by 680% in Q3 2024, buying an estimated $3.5M and bringing the position to 17,958 shares worth $4.38M. The position accounts for 0.01% of the portfolio, ranked #1010.

PEAK6 Investments first reported a position in RMD in Q1 2019 and has held it in 13 quarters since. The position peaked at $9.53M in Q1 2024. 801 funds tracked by Wall St. Rank hold RMD as of Q3 2024.

  • PEAK6 Investments held 17,958 shares of ResMed worth $4.38M as of Q3 2024.
  • PEAK6 Investments bought 15,657 ResMed shares in Q3 2024, an estimated $3.5M.
  • ResMed made up 0.01% of PEAK6 Investments's portfolio in Q3 2024, its #1010 holding.
  • PEAK6 Investments first reported a position in ResMed in Q1 2019 and has held it in 13 quarters since.
  • PEAK6 Investments's ResMed position peaked at $9.53M in Q1 2024.
  • 801 funds tracked by Wall St. Rank held ResMed as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.